Antibodies As Drugs Keystone Symposia- NOW April 27-30, 2022

Therapeutic antibodies continue to dominate the list of top biologic drugs, revolutionizing the treatment of diseases from cancer to chronic inflammatory diseases, allergy and infections. However, along with their recent expansion, the emergence of resistance and escape mechanisms is becoming increasingly problematic.   

This Keystone Symposia conference will bring together academic and industry players to address not only the latest methodological and technological advances in antibody therapeutics, but also paradigm-shifting concepts to tackle resistance challenges. The program will cover recent breakthroughs particularly in bispecific antibody engineering, highlighting technologies to improve functionalities, extend half-life and boost clinical efficacies, particularly in immune-oncology.  

Program Highlights: 

• Repertoires, Learning and in Silico Design 
• Therapeutic Antibodies from Patients 
• Antibodies from Within: Vaccination and Delivery Technologies 
• New Targets and Tools 
• The Rise of Bispecifics 
• Novel Therapeutic Antibodies in the Clinic 
  

Register Now

Get a sneak peek into the Keynote Address by Dr. Erica Ollmann Saphire, in this exclusive KSQA interview!

Register Now

for in-person or virtual attendance

See what editors from Cell Press and other leading journals are saying about the meeting!